Table III.6: Reported Provisions Related to Compounding Qualifications and Standards, by Reporting State, as of January 1, 2016
State Pharmacy staff are required to demonstrate competence in compounding Pharmacy staff are required to demonstrate competence in sterile compounding Compliance with the U.S. Pharmacopeia (USP) Chapter 795 Pharmaceutical Compounding-Nonsterile Preparations (in part or whole) Compliance with USP Chapter 797 Pharmaceutical Compounding-Sterile Preparations (in part or whole) Compounding continuing education for licensed pharmacists and/or pharmacy technicians Sterile compounding continuing education for licensed pharmacists and/or pharmacy technicians State inspectors must have competence in sterile compounding Clean room alteration plan must be submitted for approval to the state pharmacy board Compounding facilities must be accredited or inspected by a board-approved third party Pharmacists must perform final check on a prescription compounded by a pharmacy technician Specific requirements for compounding of hazardous products, including biohazards, blood-borne pathogens, and other hazardous products
Alabama No Yes Yes No Yes No No No No Yes No
Arizona No No Yes Yes No Yes No Yes Yes Yes Don't know
Arkansas Yes Yes No Yes No No Yes No No Yes No
California - Yes No No No No Yes Yes No Yes Yes
Colorado Yes Yes No No No No Yes Yes No Yes Yes
Connecticut Yes Yes Yes Yes No No No Yes No Yes Yes
Delaware Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes
District of Columbia No No No No No No No No No Yes No
Florida Don't know Don't know No Yes No No No No No Yes Yes
Georgia Yes Yes Yes - Yes Yes Yes Yes No Yes Yes
Guam No No No No No No No No No Yes No
Hawaii No No Yes Yes No No No No No Yes No
Idaho No No No No No Yes No Yes Yes Yes Yes
Illinois No No No No No No No No No Yes No
Iowa Yes Yes Yes - No No Yes Yes Don't know Yes Don't know
Kansas No No No No No No Yes No No Yes No
Kentucky Yes Yes Yes Yes No No No No No Yes Yes
Louisiana Yes Yes Yes Yes Yes Yes Yes No No Yes No
Maine - - - - - - - - - - -
Maryland - - - - - - - - - - -
Massachusetts Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Michigan Don't know Don't know Don't know Yes Don't know Don't know Yes Don't know Yes Yes Don't know
Minnesota Yes Yes Yes Yes No No No Yes No Yes No
Mississippi No No No No No No No No No Yes No
Missouri Yes Yes No - No No Yes No No Yes No
Montana Yes Yes Yes Yes No No No Yes No Yes Yes
Nebraska Yes Yes Yes Yes Don't know Don't know Yes No No Yes -
Nevada Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes
New Hampshire No No Yes Yes Yes Yes No Yes Yes Yes Yes
New Jersey Yes Yes Yes Yes No No Yes Yes Yes Yes Yes
New Mexico No Yes Yes Yes No No No Yes No Yes Yes
New York No No No No No No No Yes No Yes No
North Carolina Yes Yes Yes Yes No No Yes No No Yes Yes
North Dakota Yes Yes Yes Yes No No No Yes Yes Yes Yes
Ohio Yes Yes Yes Yes No No Yes No Yes Yes Yes
Oklahoma Yes Yes Yes Yes No No No No No Yes No
Oregon Yes Yes Yes Yes No No No No No Yes Yes
Pennsylvania No No Yes Yes No No No Yes No Yes No
Rhode Island Yes Yes Yes Yes No No No No No Yes Yes
South Carolina Yes Yes Yes Yes Yes Yes Yes No No Yes Yes
South Dakota Yes - Yes - No No Yes Yes No Yes Yes
Tennessee No Yes No Yes No Yes Yes Yes Yes Yes Yes
Texas Yes Yes Yes Yes No Yes Yes No Yes Yes -
Utah No Yes Yes Yes No No No No No Yes No
Vermont Yes Yes Yes Yes No No No No No Yes No
Virginia Yes Yes Yes Yes No No Yes No No Yes Yes
Washington Yes Yes Yes Yes No No No Yes No Yes Yes
West Virginia - - Yes Yes No No No No No Yes Yes
Wisconsin No Yes No Don't know No No No Yes No Yes No
Wyoming Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes

Source: GAO survey of state pharmacy regulatory bodies, survey question 15. | GAO-17-363SP
Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.